Logo image of BOLNV.PA

Bollore SE (BOLNV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BOLNV - FR001400XP40 - Common Stock

5.247 EUR
-0.85 (-13.98%)
Last: 5/30/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, BOLNV scores 4 out of 10 in our fundamental rating. BOLNV was compared to 51 industry peers in the Entertainment industry. BOLNV has only an average score on both its financial health and profitability. BOLNV has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BOLNV had positive earnings in the past year.
BOLNV had a positive operating cash flow in the past year.
BOLNV had positive earnings in each of the past 5 years.
BOLNV had a positive operating cash flow in each of the past 5 years.
BOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFBOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.15%, BOLNV is in the better half of the industry, outperforming 74.47% of the companies in the same industry.
With a decent Return On Equity value of 14.99%, BOLNV is doing good in the industry, outperforming 65.96% of the companies in the same industry.
BOLNV has a Return On Invested Capital (0.75%) which is in line with its industry peers.
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROIC 0.75%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
BOLNV.PA Yearly ROA, ROE, ROICBOLNV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

BOLNV has a better Profit Margin (21.69%) than 91.49% of its industry peers.
In the last couple of years the Profit Margin of BOLNV has grown nicely.
The Operating Margin of BOLNV (2.75%) is comparable to the rest of the industry.
BOLNV has a worse Gross Margin (32.15%) than 74.47% of its industry peers.
BOLNV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
BOLNV.PA Yearly Profit, Operating, Gross MarginsBOLNV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

BOLNV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BOLNV has about the same amount of shares outstanding.
The number of shares outstanding for BOLNV has been reduced compared to 5 years ago.
The debt/assets ratio for BOLNV has been reduced compared to a year ago.
BOLNV.PA Yearly Shares OutstandingBOLNV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BOLNV.PA Yearly Total Debt VS Total AssetsBOLNV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

Based on the Altman-Z score of 1.01, we must say that BOLNV is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.01, BOLNV perfoms like the industry average, outperforming 51.06% of the companies in the same industry.
The Debt to FCF ratio of BOLNV is 5.74, which is a neutral value as it means it would take BOLNV, 5.74 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.74, BOLNV perfoms like the industry average, outperforming 57.45% of the companies in the same industry.
BOLNV has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.13, BOLNV is in the better half of the industry, outperforming 70.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Altman-Z 1.01
ROIC/WACC0.13
WACC5.85%
BOLNV.PA Yearly LT Debt VS Equity VS FCFBOLNV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.18 indicates that BOLNV should not have too much problems paying its short term obligations.
BOLNV's Current ratio of 1.18 is fine compared to the rest of the industry. BOLNV outperforms 68.09% of its industry peers.
BOLNV has a Quick Ratio of 1.08. This is a normal value and indicates that BOLNV is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BOLNV (1.08) is better than 63.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.08
BOLNV.PA Yearly Current Assets VS Current LiabilitesBOLNV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 700.00% over the past year.
Measured over the past years, BOLNV shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.57% on average per year.
Looking at the last year, BOLNV shows a decrease in Revenue. The Revenue has decreased by -1.39% in the last year.
BOLNV shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -33.92% yearly.
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A

3.2 Future

BOLNV is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.24% yearly.
BOLNV is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -46.45% yearly.
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BOLNV.PA Yearly Revenue VS EstimatesBOLNV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
BOLNV.PA Yearly EPS VS EstimatesBOLNV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.20, the valuation of BOLNV can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of BOLNV indicates a rather cheap valuation: BOLNV is cheaper than 91.49% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.59, BOLNV is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 57.72, the valuation of BOLNV can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BOLNV is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, BOLNV is valued quite expensively.
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
BOLNV.PA Price Earnings VS Forward Price EarningsBOLNV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BOLNV.
BOLNV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BOLNV is cheaper than 72.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.1
EV/EBITDA 8.16
BOLNV.PA Per share dataBOLNV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as BOLNV's earnings are expected to decrease with -4.24% in the coming years.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y1.21%
EPS Next 3Y-4.24%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.51%, BOLNV has a reasonable but not impressive dividend return.
BOLNV's Dividend Yield is rather good when compared to the industry average which is at 0.85. BOLNV pays more dividend than 87.23% of the companies in the same industry.
BOLNV's Dividend Yield is comparable with the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

The dividend of BOLNV has a limited annual growth rate of 3.53%.
Dividend Growth(5Y)3.53%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

BOLNV pays out 7.97% of its income as dividend. This is a sustainable payout ratio.
DP7.97%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
BOLNV.PA Yearly Income VS Free CF VS DividendBOLNV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BOLNV.PA Dividend Payout.BOLNV.PA Dividend Payout, showing the Payout Ratio.BOLNV.PA Dividend Payout.PayoutRetained Earnings

Bollore SE

EPA:BOLNV (5/30/2025, 7:00:00 PM)

5.247

-0.85 (-13.98%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-17 2025-03-17/amc
Earnings (Next)07-28 2025-07-28
Inst Owners11.91%
Inst Owner ChangeN/A
Ins Owners5.66%
Ins Owner ChangeN/A
Market Cap14.74B
Revenue(TTM)3.13B
Net Income(TTM)3.91B
Analysts77.5
Price Target5.88 (12.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.06
Dividend Growth(5Y)3.53%
DP7.97%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.59%
PT rev (3m)-11.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.3%
EPS NY rev (3m)-41.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-85.67%
Revenue NY rev (3m)-85.67%
Valuation
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
P/S 0.82
P/FCF 13.1
P/OCF 8.85
P/B 0.56
P/tB 1.9
EV/EBITDA 8.16
EPS(TTM)0.64
EY12.2%
EPS(NY)0.09
Fwd EY1.73%
FCF(TTM)0.4
FCFY7.63%
OCF(TTM)0.59
OCFY11.29%
SpS6.42
BVpS9.3
TBVpS2.76
PEG (NY)N/A
PEG (5Y)0.16
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROCE 1.01%
ROIC 0.75%
ROICexc 0.88%
ROICexgc 1.59%
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
FCFM 6.24%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Debt/EBITDA 2.18
Cap/Depr 48.98%
Cap/Sales 2.99%
Interest Coverage 6.55
Cash Conversion 104.18%
Profit Quality 28.75%
Current Ratio 1.18
Quick Ratio 1.08
Altman-Z 1.01
F-Score7
WACC5.85%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.01%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A
EBIT growth 1Y17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-81.29%
EBIT Next 3Y-32.79%
EBIT Next 5YN/A
FCF growth 1Y70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.28%
OCF growth 3Y-52.89%
OCF growth 5Y-40.98%

Bollore SE / BOLNV.PA FAQ

What is the fundamental rating for BOLNV stock?

ChartMill assigns a fundamental rating of 4 / 10 to BOLNV.PA.


What is the valuation status for BOLNV stock?

ChartMill assigns a valuation rating of 4 / 10 to Bollore SE (BOLNV.PA). This can be considered as Fairly Valued.


What is the profitability of BOLNV stock?

Bollore SE (BOLNV.PA) has a profitability rating of 5 / 10.


How financially healthy is Bollore SE?

The financial health rating of Bollore SE (BOLNV.PA) is 5 / 10.


Is the dividend of Bollore SE sustainable?

The dividend rating of Bollore SE (BOLNV.PA) is 4 / 10 and the dividend payout ratio is 7.97%.